文献速递青光眼

青光眼患者泪液中基质金属蛋白酶2和9的功能活性

Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

横断面研究收集113例患者148眼及白内障手术对照的泪液,用明胶酶谱法检测MMP-9和MMP-2活性,发现原发性开角型青光眼、原发性闭角型青光眼和剥脱综合征眼MMP-9活性较对照显著升高,而剥脱性青光眼眼显著降低;作者认为早期青光眼泪液MMP-9活性升高可作为泪液预测生物标志物。

要点

  • 原发性开角型青光眼、原发性闭角型青光眼和剥脱综合征眼泪液MMP-9活性较白内障对照显著升高。
  • 剥脱性青光眼眼MMP-9表达显著降低,作者认为晚期阶段降解反应耗竭。
  • 作者认为早期青光眼泪液MMP-9活性升高可作为泪液预测生物标志物。

核心结论

  • 早期青光眼和剥脱综合征泪液MMP-9活性升高,提示细胞外基质降解激活,可作为泪液预测生物标志物。
  • 晚期阶段MMP-9表达降低,提示降解反应耗竭。

研究设计与样本

  • 横断面研究,用Schirmer试纸采集113例患者148眼泪液,包括未用药的原发性开角型青光眼、原发性闭角型青光眼、剥脱综合征和剥脱性青光眼患者,并与接受白内障手术的对照比较。
  • 用明胶酶谱法分析泪液MMP-9和MMP-2功能活性;从接受白内障手术者下象限采集15份Tenon囊组织,用免疫组化分析MMP-9蛋白表达。
  • 分析过氧化氢应激对人小梁网细胞中MMP-9体外活性的影响。

主要发现

  • 泪液MMP-9活性在原发性开角型青光眼(n=27)、原发性闭角型青光眼(n=24)和剥脱综合征(n=40)眼较对照(n=35)显著升高。
  • 泪液MMP-9活性在青光眼眼较中/重度青光眼显著升高(P < 0.001)。
  • 剥脱性青光眼(n=22)眼MMP-9表达显著降低。
  • Tenon囊免疫组化显示原发性青光眼眼MMP-9表达增加。
  • 人小梁网细胞在800和1000 μM过氧化氢应激2至3小时、约80%细胞死亡条件下,明胶酶谱显示MMP-9活性增加,并经Western和免疫荧光试验确认。

临床怎么用

  • 作者认为早期青光眼泪液MMP-9活性升高可作为泪液预测生物标志物。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the differential expression of tear matrix metalloproteinases (MMP) 2 and 9 in of patients with various forms of glaucoma. METHODS: Tear samples were collected with a Schirmer's strip from 148 eyes of 113 patients (medically naïve patients with primary open-angle [POAG] or angle closure glaucoma [PACG] and those with pseudoexfoliation syndrome [PXF] or glaucoma [PXG]). These were compared to patients undergoing cataract surgery (controls) for this cross-sectional study. Functional activities of tear MMP-9 and MMP-2 were analyzed by gelatin zymography. Tenon's capsules (n = 15) were harvested from the inferior quadrant in those undergoing cataract surgery and protein expression of MMP-9 was analyzed by immunohistochemistry (IHC). Hydrogen peroxide (H2O2) stress-induced effects on in vitro activities of MMP-9 in human trabecular meshwork (HTM) cells were analyzed. RESULTS: The MMP-9 activity in tears was increased significantly in POAG, (n = 27), PACG (n = 24), and PXF (n = 40) eyes compared to controls (n = 35), and was increased significantly in eyes with glaucoma compared to moderate/severe glaucoma (P < 0.001). The MMP-9 expression was significantly lower in PXG (n = 22) eyes. Immunohistochemistry of Tenon's capsule revealed increased expression of MMP-9 in primary glaucoma eyes. Increased MMP-9 activity was seen in in vitro by gelatin zymography and was confirmed by Western and immunofluorescent assay on HTM upon 800 and 1000 μM H2O2-induced stress for 2 to 3 hours with approximately 80% cell death. CONCLUSIONS: Increased tear MMP-9 activity in early glaucoma and pseudoexfoliation syndrome suggesting activation of extracellular matrix (ECM) degradation can be used as a tear-based predictive biomarker. Decreased expression in advanced stages suggests exhaustion of the degradation response.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sahay P, Rao A, Padhy D, et al. Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma. Invest Ophthalmol Vis Sci. 2017. PMID: 28586796. doi:10.1167/iovs.17-21723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。